{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-040585","form_type":"8-K","ticker":"SONX","cik":"0001407973","company_name":"Sonendo, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.818446+00:00","generated_at":"2026-06-11T21:44:03.593564+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sonendo Q2 revenue up 5% to $11M; net loss widens to $17.7M; guides FY rev $44-46M","bullets":["Total revenue $11.0M (+5% YoY); procedure instrument revenue $5.6M (+16% YoY).","Gross margin fell to 10% from 24% due to $1.7M Gen3 console and $1.2M legacy instrument inventory charges.","Net loss $17.7M vs $15.1M; operating loss $17.0M vs $14.3M.","Cash & short-term investments $65.9M. Guides Q3 revenue $10.2-10.6M; FY 2023 $44-46M.","Installed base 1,040 units; CleanFlow now indicated for anterior teeth."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-040585","json":"https://secwatch.observer/filing/0000950170-23-040585.json","markdown":"https://secwatch.observer/filing/0000950170-23-040585.md","text":"https://secwatch.observer/filing/0000950170-23-040585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1407973/000095017023040585/0000950170-23-040585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1407973/000095017023040585/sonx-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:44:03.593564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d2502f78aa492f4f5a91cb3f4dd06a14e78ad2b","claim":"Sonendo, Inc. reported the quarter ended June 30, 2023 results: revenue $11.0 million, net income $17.7 million. Guidance reaffirmed.","evidence_excerpt":"dental technology company and developer of the GentleWave® System, today reported financial results for the quarter ended June 30, 2023. Recent Highlights • Total revenue of $11.0 million for the second quarter of 2023, representing growth of 5%, compared to prior year period • Procedure instrument revenue of $5.6 million for the second quarter of 2023,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1407973/000095017023040585/0000950170-23-040585-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$11.0 million"},{"label":"Net income","value":"$17.7 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}